Days
Hours
Minutes
Seconds

March 4, 2023

About

Desert Liver Retreat

We provide a superior scientific program and a fun opportunity to network with colleagues seeking an update in state-of-the-art liver disease care. Our exhibitors are chosen as excellent providers of important products and services to our community.

Target Audience

This event is intended for MDs, DOs, PAs, NPs, RNs, residents, fellows, and clinical research personnel who are involved in the care of patients with liver disease.

Educational Objectives

After attending this event the participant should be better able to:

  • Utilize most recent guidelines for screening and diagnosing patients at risk of chronic liver disease

  • Develop an evidence-based treatment regimen for chronic liver disease using latest clinical evidence

  • Communicate disease and treatment options to patients

  • Recognize and communicate risks and benefits of therapy

  • Recognize differential diagnosis for NAFLD & NASH

  • Characterize risk factors for PBC & be able to discuss different therapies for PBC

  • Identify diagnostic approaches for HCC and treatment options

  • Explain diagnostic criteria and diagnostic tools for minimal and overt HE

  • Define diagnostic and therapeutic strategies for HCC

  • Demonstrate understanding of the diagnostic approaches for PSC and the role of liver biopsy as well as what therapies are used for PSC and when

  • Demonstrate understanding of different currently available treatment options for different clinical manifestations of portal hypertension

  • Choose different interventions and treatment approaches to minimize inpatient health care utilization for patients with liver disease

  • Describe the hepatic manifestations of COVID-19 infections including acute hepatic injury and cholangitis

Jointly provided by Postgraduate Institute for Medicine and Pinnacle Clinical Research, PLLC.

Educational grant support is pending and any confirmed support received will be disclosed in future course materials.

Accreditation Statements

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Arizona Liver Health, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Educational grant support is pending and any confirmed support received will be disclosed in future course material.

Physician Assistant Continuing Medical Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 7 CME credits for activities planned in accordance with AAPA CME Criteria.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 7.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosures

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Heather Walters prior to the live event at 214.536.1919.

Agenda

7:00 AM - 8:30 AM

Registration, Breakfast, Exhibits in Foyer

7:30 AM - 8:30 AM

Independently Sponsored Event

Intercept Pharmaceuticals

8:30 AM - 8:35 AM

Opening Remarks

SESSION ONE

Moderator: Naim Alkhouri, MD, FAASLD

Panelists: Amit Singal, MD, MS, FAASLD
Richard Finn, MD
Richard Manch, MD, FAASLD, FACP, FACG

8:35 AM - 9:00 AM

Early Detection of HCC: New Frontiers

Amit Singal, MD, MS, FAASLD

9:00 AM - 9:25 AM

Update on Systemic HCC and Cholangiocarcinoma Rx

Richard Finn, MD

9:25 AM - 9:50 AM

Benign Liver Lesions

Richard Manch, MD, FAASLD, FACP, FACG

9:50 AM - 10:15 AM

Panel Discussion

10:15 AM - 10:30 AM

Break & Exhibits in Foyer

SESSION TWO

Moderator: Naim Alkhouri, MD, FAALSD

Panelists: Jinendra Satiya, MD
Mazen Noureddin, MD, MHSc Stephen Harrison, MD, FACP, FAASLD
Samuel Klein, MD

10:30 AM - 10:55 AM

NAFLD Diagnosis From A-Z: Everything the PCP and Specialist Should Know

Mazen Noureddin, MD, MHSc

10:55 AM - 11:20 AM

NAFLD Management: Available Options Today and by the End of 2023

Naim Alkhouri, MD, FAASLD

11:20 AM - 11:45 AM

Looking into the Crystal Ball: The Future of NAFLD Treatment

Stephen Harrison, MD, FACP, FAASLD

11:45 AM - 12:15 PM

Obesity Management in the Context of NAFLD

Samuel Klein, MD

12:15 PM - 12:30 PM

Panel Discussion

12:30 pm - 1:30 pm

Independently Sponsored Event

Madrigal Pharmaceuticals

12:30 PM - 1:45 PM

Lunch & Exhibits in Foyer

SESSION THREE

Moderator: Anita Kohli, MD

Panelists: Robert Gish, MD, FAASLD,
Marcelo Kugelmas, MD, FAASLD, FACP,
Naim Alkhouri, MD, FAASLD

1:45 PM - 2:10 PM

Testing & Treatment for HBV/HDV

Robert Gish, MD, FAASLD

2:10 PM - 2:35 PM

HCV Update: Screening and Therapy

Anita Kohli, MD

2:35 PM - 3:00 PM

PBC & PSC: Epidemiology and Treatment

Marcelo Kugelmas, MD, FAASLD, FACP

3:00 PM - 3:25 PM

Pediatric Liver Disease for the Adult Medical Provider

Naim Alkhouri, MD, FAASLD

3:25 PM - 3:35 PM

Panel Discussion

3:35 PM - 3:50 PM

Break & Exhibits in Foyer

SESSION FOUR

Moderator: Jacqueline O'Leary, MD, MPH

Panelists: Jasmohan Bajaj, MD, FAASLD
Toufic Kachaamy, MD

3:50 PM - 4:15 PM

Preventing Complications in Cirrhosis

Jacqueline O'Leary, MD, MPH

4:15 PM - 4:40 PM

The Microbiome in Cirrhosis

Jasmohan Bajaj, MD, MS, FAASLD, FACG, AGAF

4:40 PM- 5:05 PM

Endo-Hepatology: A New Frontier

Toufic Kachaamy, MD, FASGE, AGAF

5:05 PM - 5:20 PM

Panel Discussion

5:20 PM - 5:25 PM

Independently Sponsored Event

Perspectum LiverMultiScan

5:25 PM - 5:30 PM

Concluding Remarks

Reception to Follow for Registered Attendees and Sponsors

Course Directors

Desert Liver Conference Faculty

Fees

Registration Fees

Early Bird Before 12/30

Regular After 12/30

In-person attendance (includes CME/MOC) ++ may be subject to facility and service fees

$125++

$150++

In-person attendance, CEU, non-CME (nurses, fellows/students, and others not requesting CME credits, research personnel) ++ may be subject to facility and service fees

$75++

$100++

Virtual attendance (includes CME and non-CME) ++ may be subject to facility and service fees

$100++

$125++

Thank You Diamond Sponsors

Thank You Top Sponsor

Thank You Platinum Sponsors

Thank You Gold Sponsor

Thank You Silver Sponsors

Venue Information

Hyatt Regency Scottsdale Resort & Spa At Gainey Ranch

7500 E Doubletree Ranch Rd, Scottsdale, AZ 85258

Phone: (480) 444-1234